NingBo Junyan Hongshi BiosciencesOrganizationGet new research by emailTrialsJS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction AdenocarcinomaPhase 3, Recruiting, 600 people, May 13, 2026Sources: clinicaltrials.gov